VYNE Therapeutics (NASDAQ:VYNE) Stock Rating Lowered by Wall Street Zen
Wall Street Zen cut shares of VYNE Therapeutics (NASDAQ:VYNE – Free Report) from a hold rating to a sell rating in a research report released on Thursday. Separately, HC Wainwright reduced their price objective on shares of VYNE Therapeutics from $5.75 to $4.50 and set a “buy” rating for the company in a research report […]
Wall Street Zen cut shares of VYNE Therapeutics (NASDAQ:VYNE – Free Report) from a hold rating to a sell rating in a research report released on Thursday. Separately, HC Wainwright reduced their price objective on shares of VYNE Therapeutics from $5.75 to $4.50 and set a “buy” rating for the company in a research report […]
